This systematic review investigates the efficacy and safety of various pharmacological treatments for neuropsychiatric symptoms in Alzheimer’s Disease patients. It concludes that cholinesterase inhibitors (ChEIs) and atypical antipsychotics could improve neuropsychiatric symptoms in these patients, but with poor patient safety outcomes.
Full Text Link (Note: This article requires a suitable Athens password, a journal subscription or payment for access).
Wang, J. Yu, JT. Wang, HF. [et al] (2014). Pharmacological treatment of neuropsychiatric symptoms in Alzheimer’s Disease: a systematic review and meta-analysis. Journal of Neurology, Neurosurgery and Psychiatry. May 29th 2014. [Epub ahead of print].